In this regard, it has been shown that administration of L-carnitine at a dose of 1000 mg/d for 12 weeks in cases with coronary artery disease causes a significant reduction in the level of inflammatory biomarkers such as TNF-α and IL-6. The gene discussed is IL6; the disease is coronary artery disorder.